Century-old vaccine found to protect type 1 diabetics from infectious diseases

Medical Xpress / Massachusetts General Hospital / iScience ^ | May 22, 2024 | Denise Faustman, MD, Ph.D. et al

[ConservativeMind]

In new research, investigators show that the 100-year-old Bacillus Calmette-Guérin (BCG) vaccine, originally developed to prevent tuberculosis, protects individuals with type 1 diabetes from severe COVID-19 disease and other infectious diseases.

Two back-to-back randomized double-blinded placebo-controlled trials found that the BCG vaccine provided continuous protection for nearly the entire COVID-19 pandemic in the US, regardless of the viral variant.

The MGH Phase II and Phase III clinical trials testing BCG differed from other BCG trials in important ways. Instead of receiving one dose of BCG, participants received five or six doses of a particularly potent strain of BCG vaccine. The US participants were followed for a total of 36 months instead of weeks or months.

And importantly, the US population had never received BCG vaccines, so these clinical trials were not booster trials.

During the earlier Phase II trial (January 2020 to April 2021) when the virus was more lethal but less transmissible, the BCG vaccine's efficacy was 92%, comparable to the efficacy of the Pfizer and Moderna COVID-19 vaccines in healthy adults.

Over the full 34 months of the US COVID-19 pandemic, the BCG vaccine had a significant efficacy of 54.3%. The investigators also found that the BCG-treated participants had lower rates of viral, bacterial, and fungal infections as well as COVID-19 disease itself.

The BCG vaccine confers an immunity that likely lasts decades, a clear advantage to the COVID-19 vaccine and vaccines against other infectious diseases, such as influenza, where the duration of effectiveness is only two or three months.

Some of the BCG-treated participants also received the commercially available COVID-19 vaccines during the Phase III trial. The investigators observed that the Pfizer, Moderna, and Johnson & Johnson vaccines did not protect people with type 1 diabetes against COVID-19.

[ConservativeMind]

The COVID vaccines did not protect Type 1 diabetics from infection, at all, while the BCG vaccine prevented it 54.3%, while also preventing numerous other infections.

[ConservativeMind]

The “Take Charge Of Your Health” Ping List
This high volume ping list is for health articles and studies which describe something you or your doctor, when informed, may be able to immediately implement for your benefit.

Email me to get on either the “Common/Top Issues” (20 - 25% fewer pings) or “Everything” list.

[E. Pluribus Unum]

Can’t make any money on a vaccine with a patent that expired decades ago.

[ZinGirl]

Ditto. “Which equals SAVE”. :)

[small farm girl]

"the BCG vaccine's efficacy was 92%, comparable to the efficacy of the Pfizer and Moderna COVID-19 vaccines in healthy adults."
Comparable to the covid vaccines in healthy adults, lol. Lost me there.

[E. Pluribus Unum]

Still gaslighting after all these years.

[Secret Agent Man]

And its an actual vaccine

Not a mrna genentic therapy shot they molested and warped the definition of vaccine to shoehorn this into

[Valpal1]

Does it do the same for non diabetics?

[Reddy]

Is this the same BCG used intravesical for bladder cancer? There has been a huge shortage of this drug.